Background. The aim of this study was to investigate the changes in oxygen consumption during liver transplantation and to examine the relationship between intraoperatively elevated systemic oxygen consumption and postoperative liver function. Methods. This study was performed in 33 adult patients undergoing liver transplantation between September 2011 and March 2014. We measured intraoperative oxygen consumption through the use of indirect calorimetry, preoperative and intraoperative data, liver function tests, and postoperative complications and outcomes. Results. The mean age of patients was 52 AE 9.7 years; 14 (42%) of them were women. Average Model for End-Stage Liver Disease scores were 20 AE 8.9. Oxygen consumption significantly increased after reperfusion from 172 AE 30 mL/min during the anhepatic phase to 209 AE 30 mL/min (P < .0001). We divided patients into 2 groups according to the increase in oxygen consumption after reperfusion (oxygen consumption after reperfusion minus anhepatic phase oxygen consumption: 40 mL/min increase as cutoff). The higher consumption group had a longer cold ischemia time and higher postoperative aspartate aminotransferase and alanine aminotransferase levels as compared with the lower oxygen consumption group. There were no statistically significant differences in major postoperative complications, but the higher oxygen consumption group tended to have shorter hospital stays than the lower consumption group (58 versus 95 days). Conclusions. We have demonstrated that oxygen consumption significantly increased after reperfusion. Furthermore, this increased oxygen consumption was associated with a longer cold ischemia time and shorter hospital stays.
T HE LITERATURE suggests that approximately 6000 liver transplantations have been performed worldwide [1] . There is currently a waiting list of 17,267 people for liver transplants in the United States [1] . Although liver transplantation has become the preferred treatment for many types of end-stage liver diseases, the procedure still carries significant perioperative morbidity and mortality rates [2] .
Recently, advances in organ preservation, surgical technique, and immunosuppressive therapy have resulted in improved outcomes after liver transplantation [3] . However, despite these improvements, primary nonfunction and graft dysfunction do occur in liver transplantation recipients [4e7] .
Graft dysfunction after liver transplantation is associated with ischemia-reperfusion injury [8, 9] . This injury includes oxidative stress and endothelial cell damage, which results in graft dysfunction [8, 9] . However, there are no specific markers of ischemia reperfusion injury [10] . Although some pro-inflammatory mediators and markers have been tested, their clinical significance is still questionable. Hence, a clinically relevant marker of ischemia reperfusion injury is still required.
Several reports have suggested that oxygen consumption during liver transplantation can reflect graft function after ischemia-reperfusion [11, 12] . Historically, oxygen consumption was measured by use of the Fick method [11e13]. However, this requires multiple blood samples from different anatomical sites. Oxygen consumption can also be measured by use of indirect calorimetry [14e19]. This requires only exhaled gas sampling and can be measured continuously. This is useful for nutritional management in critically ill patients [17] .
In the present study, with the use of indirect calorimetry, we aimed to measure the changes in oxygen consumption during liver transplantation. Thereafter, we also examined the relationship between the increased intraoperative oxygen consumption after reperfusion and the results of postoperative liver enzyme tests.
METHODS
This study was performed in 33 adult patients undergoing liver transplantation for hepatic insufficiency between September 2011 and March 2014 at our hospital. Patients who underwent multiple organ transplantations and re-transplantations were included, but children younger than 18 years of age were excluded. The study was approved by the institutional review board of our hospital, and informed consent was obtained from patients or their guardians. The study was performed in accordance with the ethical standards of the Declaration of Helsinki.
All patients received anesthesia with the use of inhalational anesthetics. Before induction, the patients were monitored for arterial blood pressure, electrocardiogram, and oxygen saturation (SpO 2 ). Anesthesia was induced with intravenous propofol (1 to 2 mg/kg) and fentanyl (2 to 4 mg/kg) and rocuronium bromide (0.6 mg/kg) to facilitate tracheal intubation. Anesthesia was maintained with inhalational anesthesia, infusion of 0.1 to 0.2 mg/kg/min remifentanil, and intermittent injection of fentanyl. Muscle relaxation was achieved with rocuronium. After tracheal intubation, the patients' lungs were mechanically ventilated by means of the pressure-controlled mode with 40% to 60% oxygen and with a positive end-expiratory pressure of approximately 5 to 7 mm Hg to maintain the partial pressure of arterial oxygen (PaO 2 ) at greater than 100 mm Hg. Respiratory rate was adjusted to maintain the partial pressure of arterial carbon dioxide (PaCO 2 ) within the normal range. After the induction, PA and central venous catheters were placed. We aimed to achieve a mean arterial pressure of >60 mm Hg by monitoring cardiac index, SvO 2 , and central venous pressure without any specific targets. Lactated Ringer's solution, albumin, and fresh-frozen plasma administration was guided by cardiovascular performance and requirements for clotting factors, respectively. Blood losses were replaced with packed red cells to maintain hemoglobin above 7 g/dL, according to our anesthesia protocol.
With the use of a Deltatrac metabolic monitor (Datex-Ohmeda), we measured systemic oxygen consumption (VO 2 ) intraoperatively at the following times: at induction of anesthesia, in the preanhepatic phase, anhepatic phase, 1 hour after reperfusion, and at the end of skin closure. The Deltatrac metabolic monitor is an open-system, indirect calorimetry device equipped with a fast paramagnetic oxygen sensor to measure a differential signal between inspired and expired gases and a gas dilution system to measure flow [19] .
Measurements were commenced when the patient was in a stable state shortly after intubation over a period of 5 minutes. After that, the measurements were continuous (every minute). The mean of these single measurements was calculated and compared with the assumed VO 2 values [18, 19] . On the basis of the increased rate of VO 2 after reperfusion, calculated as the difference between oxygen consumption after reperfusion and anhepatic phase oxygen consumption, in relation to assumed oxygen consumption values, we classified the patients into 2 groups: the higher increase rate group (H group) and the lower increase rate group (L group) (according to the calculation of oxygen consumption after reperfusion minus anhepatic phase oxygen consumption: 40 mL/min increase as cutoff).
We The changes in VO 2 were assessed by use of the paired t test, and the two groups were compared by use of the unpaired t test. We also investigated associated factors for increased oxygen consumption after reperfusion and compared the two groups regarding postoperative liver enzyme levels. All data are expressed as mean values AE standard deviation. We considered a value of P < .05 to indicate a significant difference.
RESULTS
From September 2011 to March 2014, 33 patients, 19 men and 14 women (mean age, 52 AE 9.7 years; mean BMI, 22 AE 4.5), underwent living donor liver transplantation (LDLT) at our hospital. Underlying diseases of the recipients included liver cirrhosis by viral hepatitis in 25 patients, alcoholic hepatitis in 2 patients, primary biliary cirrhosis in 2 cases, and other diseases in 4 cases. The average MELD score of these patients was 20 AE 8.9, and average ChildPugh score was 11 AE 2.1. Preoperative donor evaluation revealed normal liver biochemistry and bilirubin levels. The surgical time of the recipients was 587 AE 135 minutes; and cold and warm ischemia times of the graft were 201 (127 to 275) minutes and 49 AE 23 minutes, respectively. Average anhepatic time was 161 AE 63 minutes. The GW/RBW ratio was 1.61 AE 0.82, and average blood loss during the recipient operation was 7190 AE 5280 mL.
Intraoperative oxygen consumption changed significantly during LDLT (P < .0001). VO 2 was 205 AE 33 mL/min at the induction of anesthesia, 197 AE 33 mL/min in the preanhepatic phase, and 172 AE 30 mL/min in the anhepatic phase. Thus, during LDLT, VO 2 appears to decrease until the anhepatic phase. VO 2 increased significantly to 209 AE 30 mL/min after reperfusion (P < .05) compared with the anhepatic phase (Fig 1) . Furthermore, this increase in oxygen consumption was unrelated to changes in mean arterial pressure, cardiac index, and SvO 2 .
Classification of the patients according to the difference in oxygen consumption between reperfusion and the anhepatic phase, that is, based on the increased rate of VO 2 after reperfusion, put 17 patients in the higher increased rate group (H group) and 16 in the lower increased rate group (L group). The H group had a longer cold ischemia time than did the L group (275 AE 48 minutes versus 122 AE 49 minutes; P ¼ .03) There were, however, no significant differences between the L and H groups in terms of other preoperative and intraoperative variables (Table 1) .
We also compared the values of conventional liver function parameters preoperatively and on POD 0, 1, 2, 3, and 7 between the two groups (Fig 2) . The H group tended to have higher AST and ALT values on POD 1, 2, and 3 compared with the L group. In the H group, AST and ALT values peaked on POD 1 and then decreased to preoperative values. On the other hand, the L group had stable AST and ALT levels during the observation period (Fig 2) .
We also investigated major postoperative variables, including the incidence of kidney dysfunction requiring postoperative hemodialysis, reoperation due to bleeding, acute rejection, need for mechanical ventilation for over 1 week, ICU stay, hospital stay, and survival at 6 months. There were no statistically significant differences in these variables between the two groups (Table 1) . However, the H group tended to have a shorter hospital stay than did the L group (58 versus 95 days).
DISCUSSION
In the present study, we prospectively measured systemic oxygen consumption during liver transplantation with the use of indirect calorimetry. We also examined the relationship between intraoperative VO 2 after reperfusion and postoperative liver enzyme levels. We found that oxygen consumption significantly increased after reperfusion and that this increase in oxygen consumption was associated with a longer cold ischemia time and higher liver enzyme levels postoperatively and with a shorter hospital stay. VO 2 significantly increased after reperfusion during liver transplantation. Some previous reports that used the Fick method suggested similar trends. Takaya et al. [12] reported that oxygen consumption significantly increased in 88 patients who underwent primary liver transplantation. Steltzer et al. [11] also suggested increased VO 2 after reperfusion in 99 patients undergoing orthotopic liver transplantation.
In this study, however, we used a new noninvasive indirect calorimetry method and continuously measured total body VO 2 by monitoring expired gas [15e19]. This method has been validated in several different situations [13e16]. Gonzalez-Arevalo et al. [16] measured VO 2 in 21 critically ill, mechanically ventilated patients. Stuart-Andrews et al. [15] reported continuous monitoring of VO 2 in 30 patients undergoing cardiopulmonary bypass surgery. Compared with the Fick method, indirect calorimetry is easier, safer, and can provide continuous measurements [19] .
In the present study, this increased VO 2 was associated with a longer cold ischemia time. It has been previously reported that VO 2 significantly decreases when the ischemia time is shortened by use of veno-venous bypass [13] . Piert et al. [13] (14) 28 (14) .76 Longer hospital stay >3 months, n (%)
(38%) 2 (11%)
.08
Survival at 6 months, n (%) 14 (88%) 16 (94%) .51
Data are shown as number (%) and mean (standard deviation). Patients were classified into 2 groups, the H and L groups, based on the increased rate of oxygen consumption (VO 2 ) after reperfusion, when the H group is the higher increased rate group and the L group is the lower increased rate group.
Abbreviations: MELD, Model for End-Stage Liver Disease; CTP, Child-TurcotPugh; BMI, body mass index; CIT, cold ischemia time; WIT, warm ischemia time; ICU, intensive care unit. also suggested that VO 2 significantly decreased after hepatic artery clamping and that reperfusion causes a dramatic initial increase in VO 2 , depending on the ischemia time. In the present study, we also confirmed this relationship between ischemia time and VO 2 after reperfusion. We believe that the increase in VO 2 may be based on recovery of metabolic activity in the transplanted liver [10] .
We studied the association between the increased VO 2 and postoperative liver enzymes and clinical outcomes. This increased VO 2 was associated with higher liver enzyme levels after surgery and with a shorter hospital stay. This study shows that increased VO 2 can affect postoperative liver function. Some reports suggested that systemic VO 2 after reperfusion in patients with successful liver transplantation was higher than that in patients with graft dysfunction [11, 12] . With the use of the Fick method, Steltzer [11] reported the relationship between VO 2 and graft function in 99 patients who underwent liver transplantation. They showed that patients with primary nonfunction had much smaller increases in VO 2 than did patients with normal liver function after reperfusion. These results suggest that VO 2 after reperfusion could be a useful marker of the function of the grafted liver. The multi-factors could be associated with longer hospital stay. The relationship between ischemic time and hospital stay would be controversial.
Our study has certain limitations. We analyzed only 33 patients who underwent liver transplantation, which is a relatively small number. In this study, there were no significant differences in the clinical outcomes between the two groups. A larger sample size will be needed to determine the significance of post-perfusion VO 2 in relation to clinical outcome.
We measured systemic VO 2 with the use of indirect calorimetry. This measurement might not directly reflect local liver VO 2 [20] . Actually, a higher VO 2 after reperfusion in recipients of cadaveric whole liver grafts was associated with a poorer prognosis [20] . Further study is needed to clarify the exact significance of the increased systemic VO 2 after reperfusion.
CONCLUSIONS
In the present study, we prospectively measured VO 2 during liver transplantation by use of indirect calorimetry. We found that systemic VO 2 significantly increased after reperfusion. Furthermore, we also found that this increased VO 2 was associated with a longer cold ischemia time, higher liver enzyme levels after surgery, and shorter hospital stays.
